DeBrota DJ - Search Results

1

Serum Lipid and Protein Changes in Healthy Dyslipidemic Subjects Given a Selective Inhibitor of p70 S6 Kinase-1.

Leohr JK, Luffer-Atlas D, Luo MJ, DeBrota DJ, Green C, Mabry TE, Suico JG. Leohr JK, et al. Among authors: debrota dj. J Clin Pharmacol. 2018 Apr;58(4):412-424. doi: 10.1002/jcph.1032. Epub 2017 Nov 26. J Clin Pharmacol. 2018. PMID: 29178617 Clinical Trial.

2

Pharmacokinetics and pharmacodynamics of the cathepsin S inhibitor, LY3000328, in healthy subjects.

Payne CD, Deeg MA, Chan M, Tan LH, LaBell ES, Shen T, DeBrota DJ. Payne CD, et al. Among authors: debrota dj. Br J Clin Pharmacol. 2014 Dec;78(6):1334-42. doi: 10.1111/bcp.12470. Br J Clin Pharmacol. 2014. PMID: 25039273 Free PMC article. Clinical Trial.

3

Study of the analgesic effect of lanepitant in patients with osteoarthritis pain.

Goldstein DJ, Wang O, Todd LE, Gitter BD, DeBrota DJ, Iyengar S. Goldstein DJ, et al. Among authors: debrota dj. Clin Pharmacol Ther. 2000 Apr;67(4):419-26. doi: 10.1067/mcp.2000.105243. Clin Pharmacol Ther. 2000. PMID: 10801252 Clinical Trial.

4

Determination of pregnancy outcome risk rates after exposure to an intervention.

Goldstein DJ, Sundell KL, DeBrota DJ, Offen WW. Goldstein DJ, et al. Among authors: debrota dj. Clin Pharmacol Ther. 2001 Jan;69(1):7-13. doi: 10.1067/mcp.2001.112364. Clin Pharmacol Ther. 2001. PMID: 11180033 No abstract available.

5

Baseline Parameters in Clinical Trials for Nonalcoholic Steatohepatitis: Recommendations From the Liver Forum.

Patel YA, Imperial JC, Muir AJ, Anstee QM, DeBrota D, Dimick-Santos L, Filozof C, Mehta R, Sanyal AJ, Schabel E, Neuschwander-Tetri BA, Miller V; Liver Forum’s Data Standardization Working Group. Patel YA, et al. Gastroenterology. 2017 Sep;153(3):621-625.e7. doi: 10.1053/j.gastro.2017.07.024. Epub 2017 Jul 27. Gastroenterology. 2017. PMID: 28757264 Free PMC article. No abstract available.

6

The responsiveness of the Hamilton Depression Rating Scale.

Faries D, Herrera J, Rayamajhi J, DeBrota D, Demitrack M, Potter WZ. Faries D, et al. J Psychiatr Res. 2000 Jan-Feb;34(1):3-10. doi: 10.1016/s0022-3956(99)00037-0. J Psychiatr Res. 2000. PMID: 10696827 Clinical Trial.

7

The impact of restrictive entry criterion during the placebo lead-in period.

Landin R, DeBrota DJ, DeVries TA, Potter WZ, Demitrack MA. Landin R, et al. Among authors: debrota dj. Biometrics. 2000 Mar;56(1):271-8. doi: 10.1111/j.0006-341x.2000.00271.x. Biometrics. 2000. PMID: 10783806

8

The problem of measurement error in multisite clinical trials.

Demitrack MA, Faries D, Herrera JM, DeBrota D, Potter WZ. Demitrack MA, et al. Psychopharmacol Bull. 1998;34(1):19-24. Psychopharmacol Bull. 1998. PMID: 9564194 Clinical Trial.

9

An Item Response analysis of the Hamilton Depression Rating Scale using shared data from two pharmaceutical companies.

Evans KR, Sills T, DeBrota DJ, Gelwicks S, Engelhardt N, Santor D. Evans KR, et al. Among authors: debrota dj. J Psychiatr Res. 2004 May-Jun;38(3):275-84. doi: 10.1016/j.jpsychires.2003.11.003. J Psychiatr Res. 2004. PMID: 15003433

10

Assessing and interpreting treatment effects in longitudinal clinical trials with missing data.

Mallinckrodt CH, Sanger TM, Dubé S, DeBrota DJ, Molenberghs G, Carroll RJ, Potter WZ, Tollefson GD. Mallinckrodt CH, et al. Among authors: debrota dj. Biol Psychiatry. 2003 Apr 15;53(8):754-60. doi: 10.1016/s0006-3223(02)01867-x. Biol Psychiatry. 2003. PMID: 12706959

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

21 results

Search Page